ResearcherUniversity of ZagrebActive in the last 2 years

Ida Boček Pavlinac

ORCID-verified (high confidence)As of 13 November 2026

Matched on ORCID iD 0000-0002-6805-3286; OpenAlex author ID A5030149138.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 1 (first author 1, last author 0)
Pancreatic cancer trials: 0
Pancreatic cancer grants: 0
Collaborators: 1

Papers, trials and grants by year

2024: 1 paper

Papers 1

Novel acrylonitrile derived imidazo[4,5-b]pyridines as antioxidants and potent antiproliferative agents for pancreatic adenocarcinoma. First author DOI 10.1016/j.ijbiomac.2024.131239 ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Marijana Hranjec · 1 shared paper, 2024
- Paper Novel acrylonitrile derived imidazo[4,5-b]pyridines as antioxidants and potent antiproliferative agents for pancreatic … DOI 10.1016/j.ijbiomac.2024.131239 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.